| Term 
 | Definition 
 
        | *MDD*OCD
 *Panic disorder +/- agoraphobia *Bulimia *PMDD  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *MDD *OCD*SAD
 *Panic Disorder +/- agoraphobia
 *PTSD *PMDD  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *MDD*OCD
 *SAD
 *GAD
 *Panic disorder+/- agoraphobia
 *PTSD*PMDD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | *OCD *Social Anxiety disorder  *(not approved for MDD) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *MDD *GAD*SAD
 *Panic disorder +/- agroraphobia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | *MDD*GAD
 *Pain from diabetic peripheral neuropathy, FM, Chronic musculoskeletal pain  |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | *MDD*Seasonal affective disorders
 *Adjunct in smoking cessation  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *MDD *Low dose for insomnia (off label) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *MDD (esp if insomnia or anorexia present) |  | 
        |  | 
        
        | Term 
 
        | TCA's (Imipramine, Clomnipramine, Amitryptline, Doxepin, Desipramine, Nortriptyline) |  | Definition 
 
        | *MDD *Noctural enuresis (Imipramine) *Insomnia (Doxepin) *OCD (Clomipramine) *Neuropathic pain and migraine prophylaxis (unlabeled use) |  | 
        |  | 
        
        | Term 
 
        | MAOa Inhibitors (Isocarboxazid, Tranylcypromie, Phenelzine) |  | Definition 
 
        | *Atypical MDD (depression with hyperphagia or hyperinsomnia) |  | 
        |  | 
        
        | Term 
 
        | MAOb Inhibitor (Selegiline) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Depression+sexual dysfcn concerns |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Depression+wt gain concerns |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | *GAD *Panic disorder +/- agoraphobia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Panic disorder +/- agoraphobia *Seizure disorders |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Status epilepticus *Sedation/amnesia *ETOH withdrawal/agitation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Various seizure disorders *Conscious sedation |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Mood stabilizer for bipolar |  | 
        |  | 
        
        | Term 
 
        | Atypical Antipsychotics (Clozapine, Risperidone, Olanzapine, Quetiapine, Ziprasidone, Aripiprazole, Paliperidone, Asenapine, Iloperiodone, Lurasidone) |  | Definition 
 
        | *Tx of schizo *Tx of bipolar disorder (acute mania or mixed episodes; maintenance) |  | 
        |  | 
        
        | Term 
 
        | Special Indications fro Aripiprazole, Quetiapine and Olanzapine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Special Indications for Clozapine |  | Definition 
 
        | *Tx refractory schizo *Recurrent suicidal behavior risk reduction in schizo/shizoaffective disorder |  | 
        |  | 
        
        | Term 
 
        | Stimulants (Methylphenidate, Dexmethylphenidate, Dextroamphetamine, Lisdexamphetamine) |  | Definition 
 
        | *ADHD *Sx management of narcolepsy *depression in the medically ill/ICU (unlabeled use) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antihistamines (Diphenhydramine and Doxylamine) |  | Definition 
 
        | *Sleep aids (good for sleep maintenance) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Tx of insomnia (Sleep maintenance) |  | 
        |  | 
        
        | Term 
 
        | BZD's (Triazolam, Estazolam, Temazepam, Flurazepam, Quazepam) |  | Definition 
 
        | *Sleep aids (save for pts who don't respond adequately to good sleep hygiene, NBRA's, remelteon +/- low dose trazadone or doxepin) |  | 
        |  | 
        
        | Term 
 
        | NBRAs (Zaleplon, Zolpidem, Eszopiclone) |  | Definition 
 
        | *Tx of insomnia (Sleep onset and maintenance) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Tx of insomnia characterized by difficulty falling asleep (Sleep onset) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Partial seizures with complex symptomatology (psychomotor, temporal lobe) *mixed seizure patterns *tx of chronic pain syndromes  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Monotherapy or adjunctive therapy in partial seizures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Generalized tonic-clonic and complex partial seizures *prevention os seizures following head trauma/NS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Maintenace tx of bipolar disorder *Tx of seizures in Lennox-Gastaut syndrome *Not FDA approved: initial tx for newly dx'd partial epilepsy, idiopathic generalized epilepsy, and mixed seizure disorders |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Add-on thearpy in adults with partial-onset seizures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Add on thearpy for partial seizures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Seizures assoc with Lennox-Gastaut syndrome |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Tx of absence (petit mal) seizures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Adjunct for partial seizures with and without secondary generalized seizures *management of postherpetic neuropathy *restless leg syndrome |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Adjunctive for partial seizures in adults *FM*Management of peripheral neuropathies
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Tx of generalized and partial seizures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Adjunctive tx for partial seizures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Add-on therapy for complex partial seizures in adults who are refractory to several AED's *Monotherapy for infantile spasms (orphan drug) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Monotherapy and adjunctive therapy in pts with multiple seizure types (including absence seizures) *Mania assoc with bipolar disorder *Migraine prophylaxis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *AAN Recommendations: initial therapy for newly dx'd partial and mixed seizure disorders, monotherapy for refractory generalized tonic-clonic and partial seizures, migraine prophylaxis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Partial seizures *Lennox-Gastaut syndrome |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Add on therapy for adults with partial onset, myoclonic +/- primary generalized tonic-clonic seizures |  | 
        |  | 
        
        | Term 
 
        | Cholinesterase Inhibitors (Donepezil, Galantamine, Rivastigmine) |  | Definition 
 
        | *Mild to moderate Alzheimers dz |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Tx of moderate to severe Alzheimers dz |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Most effective drug for PD symptomatic tx |  | 
        |  | 
        
        | Term 
 
        | PO Dopamine Agonists (Ropinirole and Pramipexole) |  | Definition 
 
        | *Alternate 1st line or add-on therapy to levodopa *restless leg syndrome |  | 
        |  | 
        
        | Term 
 
        | SQ Dopamine Agonists (Apomorphine) |  | Definition 
 
        | *Tx of immobility ("off" episodes) in advanced PD |  | 
        |  | 
        
        | Term 
 
        | MAOb Inhibitors (Selegiline and Rasagiline) |  | Definition 
 
        | *Early PD dz-can be used as inital therapy to improve sx's  in pt with early PD *Later dz-adjunctive management when levodopa efficacy is deteriorating |  | 
        |  | 
        
        | Term 
 
        | Anticholinergics (Trihexyphenidyl, Benztropine) |  | Definition 
 
        | *Early PD dz-may be helpful in pts who present with mild tremor  *Later dz-May be used to enhance the effects of levodopa and may help with drooling |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Early PD dz-may be used as inital theapy in mild dz (resting tremor) *later dz-adjunct tx (in pts with levodopa-induced dyskinesias) |  | 
        |  | 
        
        | Term 
 
        | Triptans (Sumatriptan, Zolmitriptan, Rizatriptan, Almotriptan, Eletriptan, Naratriptan, Frovatriptan) |  | Definition 
 
        | *Early use (mild-mod pain) d/t migraines *Partial response or migraine recurrence more likely with later use (mod-severe pain) |  | 
        |  | 
        
        | Term 
 
        | Ergot products (Ergotamine, Ergotamine/caffeine, Dihydroergotamine) |  | Definition 
 
        | *Years of use for migraine (but less effective than triptans) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Management of DMII (mono or combo therapy) *Management of insulin resistance in PCOS |  | 
        |  | 
        
        | Term 
 
        | Sulfonylureas (Chlorpropamide, Glyburide, Glipizide, Glimepiride) |  | Definition 
 
        | *Management of DMII (mono and combo therapy) |  | 
        |  | 
        
        | Term 
 
        | Meglitinides (Nateglinide and Repaglinide) |  | Definition 
 
        | *Management of DMII (mono or combo therapy) |  | 
        |  | 
        
        | Term 
 
        | Thiazolideinediones (Pioglitazone and Rosiglitazone) |  | Definition 
 
        | *Management of DMII (mono or combo therapy) *Management of insulin resistance in PCOS pts
 |  | 
        |  | 
        
        | Term 
 
        | Acarbose and Miglitol (alpha-glucosidase inhibitors) |  | Definition 
 
        | *Management of DMII (mono or combo therapy) |  | 
        |  | 
        
        | Term 
 
        | Incretins (Exenatide and Liraglutide) |  | Definition 
 
        | *Management of DMII (mono or combo therapy) |  | 
        |  | 
        
        | Term 
 
        | DPP-IV inhibitors (Sitagliptin, Saxagliptin, Linagliptin) |  | Definition 
 
        | *Management of DMII (mono or combo therapy) |  | 
        |  | 
        
        | Term 
 
        | Prandial Insulins (regular, Lispro, Aspart, Glusiline) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Basal Insulin (NPH, Glargine, Detemir) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Biphasic Insulins (70 NPH/30 Regular; 30 Aspart/70 Protamine) |  | Definition 
 
        | *Less flexibility overall but good for pt unwilling to do more than 2injections/d, duration of action lasts longer in CKD pts |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *No longer 1st line for Osteoporosis b/c of increased risk of breast CA, VTE, CVA and perhaps CAD *Persistent menopausal sx's *Women with an indication for antiresorptive therapy who cannot tolerate other drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Prevention and tx of osteoporosis *Risk reduction for women with invasive breast CA |  | 
        |  | 
        
        | Term 
 
        | Disphosphonates (Etidronate and Tiludronate) |  | Definition 
 
        | *Symptomatic tx of Pagets dz of bone |  | 
        |  | 
        
        | Term 
 
        | Aminobisphosphonates (Alendronate, Ibandronate, Risedronate, Zoledronic acid) |  | Definition 
 
        | *Prevention and tx of osteoporosis (note: not pamindronate) *Hypercalcemia assoc with malignancy and Pagets dz |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Tx of osteoporosis *Prevention of skeletal-related events in pts with bone metastases from solid tumors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Tx of osteoporosis in pts at high risk of fx (for up to 2yrs) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Replacement or supplemental therapy in congenital or acquired hypothyroidism |  | 
        |  | 
        
        | Term 
 
        | Thionamides (PTU and Methimazole) |  | Definition 
 
        | *Palliative tx of hyperthyroidism as an adjunct to ameliorate hyperthyroidism in prep for surgery or RAI therapy *Management of thyrotoxic crisis |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  |